Drugs / G-CSF mobilized HLA-haploidentical donor PBSC
G-CSF mobilized HLA-haploidentical donor PBSC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03381118 | Jun 2017 → Sep 2018 | acute myeloid leukemia | St. Petersburg State Pavlov Medical University | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | G-CSF mobilized HLA-haploidentical donor PBSC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03381118 ↗ |
| Modality | Cell therapy | “peripheral blood stem cells” NCT03381118 ↗ |
| Route | Intravenous | “G-CSF mobilized HLA-haploidentical donor peripheral blood stem cells IV infusion on D0” NCT03381118 ↗ |